Cite
HARVARD Citation
Tu, L. et al. (n.d.). FRI0415 BIOSIMILAR BAT1406 VERSUS ADALIMUMAB THERAPY ON ACTIVE ANKYLOSING SPONDYLITIS: A RANDOMIZED, DOUBLE-BLINDED, MULTICENTER, CONTROLLED PHASE 3 TRIAL. Annals of the rheumatic diseases. p. 895. [Online].